Aigen Investment Management, LP Innoviva, Inc. Transaction History

Aigen Investment Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$10.73 - $13.6 $168,385 - $213,424	-15,693 Reduced 32.88%	32,036 $360,000
Q4 2022 Feb 10, 2023	BUY	$11.8 - $13.78 $563,202 - $657,705	47,729 New	47,729 $632,000
Q3 2020 Nov 06, 2020	SELL	$10.33 - $14.49 $380,319 - $533,478	-36,817 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$11.49 - $15.26 $386,891 - $513,834	33,672 Added 1070.65%	36,817 $515,000
Q1 2020 May 08, 2020	BUY	$8.11 - $15.23 $25,505 - $47,898	3,145 New	3,145 $37,000

228

78.9M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.2B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.